RenovoRx RNXT Stock
$0.91
-0.538164%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$40.84M
LOW - HIGH [24H]
$0.87
-
$0.92
VOLUME [24H]
$331.14K
P/E Ratio
0
Earnings per share
-$0.33
ISIN
US75989R1077
RenovoRx Price Chart
RenovoRx RNXT Financial and Trading Overview
| RenovoRx stock price | 0.91 USD |
| Previous Close | 0.91 USD |
| Open | 0.94 USD |
| Bid | 0.67 USD x 200 |
| Ask | 1.2 USD x 200 |
| Day's Range | 0.92 - 0.98 USD |
| 52 Week Range | 0.7 - 1.45 USD |
| Volume | 516.71K USD |
| Avg. Volume | 375.16K USD |
| Market Cap | 41.52M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.03 USD |
RNXT Valuation Measures
| Enterprise Value | 29.24M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.138 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 27.886349 |
| Price/Book (mrq) | 3.6828 |
| Enterprise Value/Revenue | 19.637 |
| Enterprise Value/EBITDA | -2.364 |
Trading Information
RenovoRx Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -32.77% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1.45 USD |
| 52 Week Low | 0.7 USD |
| 50-Day Moving Average | 0.94 USD |
| 200-Day Moving Average | 0.99 USD |
RNXT Share Statistics
| Avg. Volume (3 month) | 375.16K USD |
| Avg. Daily Volume (10-Days) | 366.74K USD |
| Shares Outstanding | 45.1M |
| Float | 39.9M |
| Short Ratio | 1.34 |
| % Held by Insiders | 3.77% |
| % Held by Institutions | 19.00% |
| Shares Short | 384.04K |
| Short % of Float | 0.88% |
| Short % of Shares Outstanding | 0.85% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -616.16% |
| Gross Margin | 78.71% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -51.57% |
| Return on Equity (ttm) | -100.47% |
Income Statement
| Revenue (ttm) | 1.49M USD |
| Revenue Per Share (ttm) | 0.04 USD |
| Quarterly Revenue Growth (yoy) | 185.80% |
| Gross Profit (ttm) | 1.17M USD |
| EBITDA | -12367000 USD |
| Net Income Avi to Common (ttm) | -12269000 USD |
| Diluted EPS (ttm) | -0.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.36M USD |
| Total Cash Per Share (mrq) | 0.27 USD |
| Total Debt (mrq) | 78K USD |
| Total Debt/Equity (mrq) | 0.69 USD |
| Current Ratio (mrq) | 7.146 |
| Book Value Per Share (mrq) | 0.25 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11301000 USD |
| Levered Free Cash Flow (ttm) | -6375625 USD |
Profile of RenovoRx
| Country | United States |
| State | CA |
| City | Mountain View |
| Address | 2570 West El Camino Real |
| ZIP | 94040 |
| Phone | 650 284 4433 |
| Website | https://renovorx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 17 |
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
Q&A For RenovoRx Stock
What is a current RNXT stock price?
RenovoRx RNXT stock price today per share is 0.91 USD.
How to purchase RenovoRx stock?
You can buy RNXT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RenovoRx?
The stock symbol or ticker of RenovoRx is RNXT.
Which industry does the RenovoRx company belong to?
The RenovoRx industry is Biotechnology.
How many shares does RenovoRx have in circulation?
The max supply of RenovoRx shares is 45.1M.
What is RenovoRx Price to Earnings Ratio (PE Ratio)?
RenovoRx PE Ratio is now.
What was RenovoRx earnings per share over the trailing 12 months (TTM)?
RenovoRx EPS is -0.33 USD over the trailing 12 months.
Which sector does the RenovoRx company belong to?
The RenovoRx sector is Healthcare.
RenovoRx RNXT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}